Trading Day Review: scPharmaceuticals Inc (SCPH) Gains Momentum, Closing at 3.41

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of scPharmaceuticals Inc (NASDAQ: SCPH) closed at $3.41 in the last session, up 1.79% from day before closing price of $3.35. In other words, the price has increased by $1.79 from its previous closing price. On the day, 0.5 million shares were traded. SCPH stock price reached its highest trading level at $3.59 during the session, while it also had its lowest trading level at $3.35.

Ratios:

We take a closer look at SCPH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.89 and its Current Ratio is at 8.08. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.70.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 07, 2023, initiated with a Buy rating and assigned the stock a target price of $20.

On December 01, 2022, Cowen started tracking the stock assigning a Outperform rating and target price of $25.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 13 ’24 when ORBIMED ADVISORS LLC bought 500,000 shares for $4.00 per share. The transaction valued at 2,000,000 led to the insider holds 5,806,670 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SCPH now has a Market Capitalization of 170636752. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.46 while its Price-to-Book (P/B) ratio in mrq is 5.56.

Stock Price History:

Over the past 52 weeks, SCPH has reached a high of $6.71, while it has fallen to a 52-week low of $3.08. The 50-Day Moving Average of the stock is -19.51%, while the 200-Day Moving Average is calculated to be -26.90%.

Shares Statistics:

According to the various share statistics, SCPH traded on average about 349.82K shares per day over the past 3-months and 832750 shares per day over the past 10 days. A total of 35.97M shares are outstanding, with a floating share count of 34.52M. Insiders hold about 31.02% of the company’s shares, while institutions hold 61.31% stake in the company. Shares short for SCPH as of 1730332800 were 4128838 with a Short Ratio of 11.80, compared to 1727654400 on 4211070. Therefore, it implies a Short% of Shares Outstanding of 4128838 and a Short% of Float of 9.33.

Most Popular